Pure Global
NCT04848961

A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer

Leveraging Mammography to Identify and Engage Women at Risk for Lung Cancer in Lung Cancer Screening
Memorial Sloan Kettering Cancer Center·Early Phase 1·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Smoking
Drug/Device/Intervention
LungTalk
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Memorial Sloan Kettering Cancer Center
Location
Hartford,Basking Ridge,Middletown,Montvale,Commack,Harrison,New York,Uniondale, United States of America
Timeline & enrollment
Phase
Early Phase 1
Start date
Apr 09, 2021
End date
Apr 09, 2023
Enrollment
150 participants
Primary outcome

Number of participants accrued through digital outreach to identify breast screening participants eligible for lung screening

Summary

The purpose of this study is to develop a digital strategy to increase awareness about lung
 cancer screening among women who are eligible to receive it. The digital strategy involves
 email communications and LungTalk, a web-based (accessed through the Internet) health
 communication tool that uses text, audio, video, and animation to increase awareness and
 knowledge about lung cancer screening. This study will focus on women who have recently
 received a screening mammogram.

ICD-10 classifications
Tobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco : harmful useDrug use
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04848961
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04848961 through Pure Global AI's free database. This Early Phase 1 trial is sponsored by Memorial Sloan Kettering Cancer Center and is currently Recruiting. The study focuses on Smoking. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.